Trial intelligence / Profile preview

Oral Etoposide with Radiotherapy for High Stage Medulloblastoma

NCT00003573Phase 2Completed

Sponsor
Children's Oncology Group
Start
Nov 1998
Primary completion
Oct 2007
Modality
Small Molecules
Countries
5
01

Overview

A Phase 2 trial of etoposide in medulloblastoma, sponsored by Children's Oncology Group. Started Nov 1998; status: completed.

02

Drugs

etoposide
03

Conditions

medulloblastoma

Beyond the preview

Go deeper on NCT00003573.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003573.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call